Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer

JAMA 2026

View at publisher
DOI: 10.1001/jama.2026.9032
Cited by: 1

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
336
Issue
6
Pages
e269032–e269032
Publication date
1 June 2026
Language
EN